GlucoSentient, Inc.

Basic Information

60 Hazelwood Drive
Champaign, IL, 61820-0000

Company Profile


Additional Details

Field Value
DUNS: 78305396
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: 2

  1. SBIR Phase II: A Novel Device for Convenient Therapeutic Drug Monitoring of Tacrolimus

    Amount: $750,000.00

    This Small Business Innovation Research (SBIR) Phase II project is aiming to develop and validate a point-of-care monitoring for tacrolimus, an immunosuppressive medication widely used by organ transp ...

    SBIR Phase II 2013 National Science Foundation
  2. SBIR Phase I: Novel Biosensor for Monitoring of Theophylline using Personal Glucose Meter

    Amount: $149,999.00

    This Small Business Innovation Research Phase I project aims to develop a new technology to utilize ubiquitous personal glucose meters (PGMs) for inexpensive and convenient at-home tests of the drug t ...

    SBIR Phase I 2012 National Science Foundation

Agency Micro-sites

US Flag An Official Website of the United States Government